Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 3
1981 1
1983 1
1989 1
1992 1
1993 15
1994 2
1995 6
1996 6
1997 8
1998 4
1999 5
2000 31
2001 47
2002 64
2003 115
2004 108
2005 124
2006 142
2007 199
2008 215
2009 213
2010 207
2011 234
2012 262
2013 282
2014 269
2015 310
2016 342
2017 369
2018 380
2019 395
2020 441
2021 503
2022 478
2023 456
2024 469
2025 544
2026 306

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,671 results

Results by year

Filters applied: . Clear all
Page 1
Levetiracetam.
Howard P, Remi J, Remi C, Charlesworth S, Whalley H, Bhatia R, Hitchens M, Mihalyo M, Wilcock A. Howard P, et al. J Pain Symptom Manage. 2018 Oct;56(4):645-649. doi: 10.1016/j.jpainsymman.2018.07.012. Epub 2018 Jul 21. J Pain Symptom Manage. 2018. PMID: 30036676 Free article. Review.
Levetiracetam for Seizure Prophylaxis in Neurocritical Care: A Systematic Review and Meta-analysis.
Fang T, Valdes E, Frontera JA. Fang T, et al. Neurocrit Care. 2022 Feb;36(1):248-258. doi: 10.1007/s12028-021-01296-z. Epub 2021 Jul 20. Neurocrit Care. 2022. PMID: 34286461
The coprimary meta-analyses examined first seizure events in (1) levetiracetam versus no antiseizure medication and (2) levetiracetam versus other antiseizure medications in all ICH, TBI, SAH, and supratentorial neurosurgery populations. ...Levetiracetam may …
The coprimary meta-analyses examined first seizure events in (1) levetiracetam versus no antiseizure medication and (2) levetirace …
Use of Phenytoin, Phenobarbital Carbamazepine, Levetiracetam Lamotrigine and Valproate in Pregnancy and Breastfeeding: Risk of Major Malformations, Dose-dependency, Monotherapy vs Polytherapy, Pharmacokinetics and Clinical Implications.
Kaplan YC, Demir O. Kaplan YC, et al. Curr Neuropharmacol. 2021;19(11):1805-1824. doi: 10.2174/1570159X19666210211150856. Curr Neuropharmacol. 2021. PMID: 33573557 Free PMC article. Review.
This paper aims to undertake a comprehensive review regarding the possible risks of four classical (phenytoin, carbamazepine, phenobarbital, and valproate) and two newer (lamotrigine and levetiracetam) AEDs during pregnancy. The review focuses on major and organ-specific m …
This paper aims to undertake a comprehensive review regarding the possible risks of four classical (phenytoin, carbamazepine, phenobarbital, …
Levetiracetam.
Nash EM, Sangha KS. Nash EM, et al. Am J Health Syst Pharm. 2001 Jul 1;58(13):1195-9. doi: 10.1093/ajhp/58.13.1195. Am J Health Syst Pharm. 2001. PMID: 11449876 Review.
The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosage and administration of levetiracetam are reviewed. Levetiracetam is an adjunctive treatment for partial-onset epileptic seizures. ...Three clinical studies have demonstrated levetir …
The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosage and administration of levetiracetam are reviewed. …
Levetiracetam-associated pancytopenia.
Unkun R, Kizilkilic EK, Delil S, Kemerdere R, Ozkara C. Unkun R, et al. Acta Neurol Belg. 2023 Aug;123(4):1625-1626. doi: 10.1007/s13760-022-02138-1. Epub 2022 Nov 7. Acta Neurol Belg. 2023. PMID: 36344882 No abstract available.
Levetiracetam in pediatrics.
Vigevano F. Vigevano F. J Child Neurol. 2005 Feb;20(2):87-93. doi: 10.1177/08830738050200020101. J Child Neurol. 2005. PMID: 15794171 Review.
Levetiracetam is a new antiepileptic drug whose efficacy and tolerability are already well known in adults. ...This review, based on the international literature, aims to identify and make known the possible indications for levetiracetam in childhood. Most studies s …
Levetiracetam is a new antiepileptic drug whose efficacy and tolerability are already well known in adults. ...This review, based on …
Levetiracetam.
Alrabiah H. Alrabiah H. Profiles Drug Subst Excip Relat Methodol. 2019;44:167-204. doi: 10.1016/bs.podrm.2019.02.003. Epub 2019 Mar 25. Profiles Drug Subst Excip Relat Methodol. 2019. PMID: 31029217
A comprehensive profile of levetiracetam is presented in this chapter which includes its description, formula, elemental analysis, appearance, uses and applications. ...
A comprehensive profile of levetiracetam is presented in this chapter which includes its description, formula, elemental analysis, ap …
Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT.
Appleton RE, Rainford NE, Gamble C, Messahel S, Humphreys A, Hickey H, Woolfall K, Roper L, Noblet J, Lee E, Potter S, Tate P, Al Najjar N, Iyer A, Evans V, Lyttle MD. Appleton RE, et al. Health Technol Assess. 2020 Nov;24(58):1-96. doi: 10.3310/hta24580. Health Technol Assess. 2020. PMID: 33190679 Free PMC article. Clinical Trial.
The Emergency treatment with Levetiracetam or Phenytoin in Status Epilepticus in children (EcLiPSE) trial was a randomised controlled trial that compared levetiracetam with phenytoin. ...None of the results showed any statistically significant or meaningful differen …
The Emergency treatment with Levetiracetam or Phenytoin in Status Epilepticus in children (EcLiPSE) trial was a randomised controlled …
Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
Marson AG, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton CO, Hughes DA, Williamson PR, Baker G, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE. Marson AG, et al. Health Technol Assess. 2021 Dec;25(75):1-134. doi: 10.3310/hta25750. Health Technol Assess. 2021. PMID: 34931602 Free article. Clinical Trial.
BACKGROUND: Levetiracetam (Keppra( ), UCB Pharma Ltd, Slough, UK) and zonisamide (Zonegran( ), Eisai Co. ...INTERVENTIONS: Participants with focal epilepsy were randomised to receive lamotrigine, levetiracetam or zonisamide. Participants with generalised or unclassi …
BACKGROUND: Levetiracetam (Keppra( ), UCB Pharma Ltd, Slough, UK) and zonisamide (Zonegran( ), Eisai Co. ...INTERVENTIONS: Participan …
Levetiracetam-induced gingival hyperplasia.
James J, Jose J, Gafoor VA. James J, et al. J Postgrad Med. 2022 Jul-Sep;68(3):168-169. doi: 10.4103/jpgm.jpgm_1059_21. J Postgrad Med. 2022. PMID: 35848684 Free PMC article.
Levetiracetam is a new generation antiseizure medication which binds to synaptic vesicle protein SV2A and inhibits the release of neurotransmitters. Gingival hyperplasia is a common side effect of conventional antiseizure medications like phenytoin, but very rare with the …
Levetiracetam is a new generation antiseizure medication which binds to synaptic vesicle protein SV2A and inhibits the release of neu …
6,671 results